Valuation: Perrigo Company plc

Market Cap 2.35B 2.14B 1.98B 1.79B 3.37B 220B 3.5B 23.95B 9.47B 119B 8.82B 8.64B 374B P/E 2026 *
-4.77x
P/E 2027 * -38.1x
Enterprise Value 5.37B 4.89B 4.52B 4.08B 7.69B 501B 7.99B 54.64B 21.6B 271B 20.13B 19.71B 855B EV / Sales 2026 *
1.34x
EV / Sales 2027 * 1.33x
Free-Float
98.95%
Yield 2026 *
6.85%
Yield 2027 * 6.94%
1 day+7.49%
1 week+2.36%
Current month+7.35%
1 month+1.86%
3 months+30.61%
6 months+58.61%
Current year+21.70%
1 week 15.75
Extreme 15.75
17.07
1 month 15.12
Extreme 15.12
17.07
Current year 9.22
Extreme 9.225
17.07
1 year 9.22
Extreme 9.225
17.07
3 years 9.22
Extreme 9.225
34.6
5 years 9.22
Extreme 9.225
43.9
10 years 9.22
Extreme 9.225
95.93
Manager TitleAgeSince
Chief Executive Officer 63 07/06/2026
Director of Finance/CFO 51 16/05/2022
Chief Operating Officer - 23/06/2025
Director TitleAgeSince
Director/Board Member 75 01/11/2014
Director/Board Member 61 07/11/2016
Director/Board Member 70 06/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
11/09/26 Exercice

Director

5,192 0.0037%
11/09/26 Exercice

Director

3,133 0.0023%
09/09/26 Exercice

Executive/Senior Manager

18,186 0.0131%
Change 5-day change 1-year change 3-year change Capi.($)
+7.49%+2.36%+26.51%-43.74% 2.19B
-2.32%-3.79%+34.24%+133.69% 1,261B
-2.15%-2.75%+36.35%+82.05% 671B
-2.33%-3.04%+22.29%+106.80% 518B
-0.69%+0.37%+31.53%+69.78% 387B
-3.90%-6.39%+42.88%+35.41% 353B
-1.35%-0.95%+28.90%+56.34% 300B
-1.13%-1.80%+0.59%+33.00% 283B
-3.07%-5.17%+29.04%+67.26% 248B
-0.75%-0.44%+32.87%+123.96% 211B
Average -1.02%-2.28%+28.52%+66.46% 423B
Weighted average by Cap. -2.09%-2.34%+30.58%+91.50%

Financials

2026 *2027 *
Net sales 4.01B 3.65B 3.38B 3.05B 5.74B 374B 5.97B 40.8B 16.13B 202B 15.03B 14.71B 638B 3.87B 3.53B 3.26B 2.95B 5.55B 362B 5.77B 39.43B 15.58B 195B 14.52B 14.22B 617B
Net income -497M -453M -419M -378M -712M -46.41B -740M -5.06B -2B -25.05B -1.86B -1.82B -79.11B -62.05M -56.59M -52.32M -47.22M -88.93M -5.8B -92.44M -632M -250M -3.13B -233M -228M -9.88B
Net Debt 3.01B 2.75B 2.54B 2.29B 4.32B 282B 4.49B 30.7B 12.14B 152B 11.31B 11.07B 480B 2.8B 2.55B 2.36B 2.13B 4.01B 262B 4.17B 28.5B 11.27B 141B 10.5B 10.28B 446B
Projected Income Statement - Annual - Perrigo Company plc
Logo Perrigo Company plc
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
8,100
Date Price Change Volume
18/11/26 $16.94 +7.49% 2,567,919
17/11/26 $15.76 -2.60% 1,719,689
16/11/26 $16.18 -0.37% 1,588,573
13/11/26 $16.24 +0.37% 1,006,741
12/11/26 $16.18 -2.24% 1,379,842
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Perrigo Company plc
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
16.94USD
Average target price
18.00USD
Spread / Average Target
+6.26%
  1. Stock Market
  2. Stocks
  3. PRGO Stock